Literature DB >> 3794143

Age at onset and rate of progression of Alzheimer's disease.

F J Huff, J H Growdon, S Corkin, T J Rosen.   

Abstract

Age at onset, duration, and severity of dementia were evaluated in 165 patients with a clinical diagnosis of Alzheimer's disease. Rate of progression of dementia was determined in 77 patients by repeated administration of the Blessed Dementia Scale (BDS). The distribution of age at onset among patients was bimodal, with a division at about age 65. Duration of dementia at the time of initial examination was shorter, and rate of progression on follow-up examination was more rapid in senile-onset (age 65 or greater) than in presenile-onset (before age 65) cases. Considerable overlap among values for the two patient groups was observed for both variables, indicating that age at onset is not a strong predictor of rate of progression of dementia in patients with Alzheimer's disease.

Entities:  

Mesh:

Year:  1987        PMID: 3794143     DOI: 10.1111/j.1532-5415.1987.tb01315.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  12 in total

1.  The economic costs of Alzheimer's disease.

Authors:  J W Hay; R L Ernst
Journal:  Am J Public Health       Date:  1987-09       Impact factor: 9.308

2.  Nonamnestic presentations of early-onset Alzheimer's disease.

Authors:  Mario F Mendez; Albert S Lee; Aditi Joshi; Jill S Shapira
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-08-07       Impact factor: 2.035

3.  The US economic and social costs of Alzheimer's disease revisited.

Authors:  R L Ernst; J W Hay
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

4.  Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease.

Authors:  Josephine Barnes; Jonathan W Bartlett; David A Wolk; Wiesje M van der Flier; Chris Frost
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: rescue by donepezil (Aricept).

Authors:  Carola Romberg; Mark P Mattson; Mohamed R Mughal; Timothy J Bussey; Lisa M Saksida
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

6.  Factors affecting the age of onset and rate of progression of Alzheimer's disease.

Authors:  J V Bowler; D G Munoz; H Merskey; V Hachinski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

7.  Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years.

Authors:  Martin R Farlow; Mary L Lilly
Journal:  BMC Geriatr       Date:  2005-01-19       Impact factor: 3.921

8.  Age-at-Onset and APOE-Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease.

Authors:  Denis S Smirnov; Douglas Galasko; Annie Hiniker; Steven D Edland; David P Salmon
Journal:  Neurology       Date:  2021-03-15       Impact factor: 11.800

9.  Epidemiology of early-onset dementia: a review of the literature.

Authors:  Renata Teles Vieira; Leonardo Caixeta; Sergio Machado; Adriana Cardoso Silva; Antonio Egidio Nardi; Oscar Arias-Carrión; Mauro Giovanni Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2013-06-14

10.  Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.

Authors:  Carina Wattmo; Åsa K Wallin
Journal:  Alzheimers Res Ther       Date:  2017-08-31       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.